Engineered NK cells can eliminate glioblastoma stem cells
HOUSTON ? Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling protein, which blocks NK cell activity. Deleting the TFG-β receptor in NK cells, however, rendered them resistant to this immune suppression and enabled their anti-tumor activity.
The findings, published today in the Journal of Clinical Investigation, suggest that engineering NK cells to resist immune suppression may be a feasible path ...

















